+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Middle East and Africa Intracranial Aneurysm Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • June 2024
  • Region: Africa, Middle East
  • Expert Market Research
  • ID: 5984419
The global intracranial aneurysm market was valued at USD 1.2 billion in 2023, with the Middle East and Africa holding a significant market share. The market is driven by the growing demand for minimally invasive treatment options. It is expected to grow at a CAGR of 8.8% during the forecast period of 2024-2032, with the values likely to attain USD 2.6 billion by 2032.

Middle East and Africa Intracranial Aneurysm Market Outlook

  • A ruptured intracranial aneurysm can be life-threatening, supported by recent data that reveals around 10% of brain aneurysms rupture each year, with about 20% of the individuals dying before hospitalization and nearly 30% dying within a span of 3 months.
  • The Middle East and Africa intracranial aneurysm market share is influenced by the rise in clinical data registries for post-marketing surveillance of medical devices used for endovascular aneurysm care. For instance, INSPIRE-A is an international registry sponsored by Medtronic plc, engaged in the assessment of flow-diverter imaging results.
  • One of the major market trends is the rising preference for minimally invasive procedures associated with reduced complications, shorter recovery times, and improved patient outcomes.

Middle East and Africa Intracranial Aneurysm Market Analysis

Intracranial aneurysms or brain aneurysms are a weakened or bulging area in the wall of a blood vessel in the brain. High blood pressure, smoking, and a family history of aneurysms are some of the risk factors for developing this balloon-like sac filled with blood. Surgical clipping, endovascular coiling, and flow diversion are some treatment options used to prevent rupture or re-rupture of the aneurysm. The growing demand for less invasive procedures associated with reduced complications, shorter recovery times, and improved patient outcomes significantly contributes to the Middle East and Africa intracranial aneurysm market growth.

When an aneurysm ruptures, it can cause bleeding into the space around the brain (subarachnoid hemorrhage), which can be life-threatening and often leads to a stroke and brain damage. Recent data reveals that around 10% of brain aneurysms rupture each year, with about 20% of the individuals dying before hospitalization and nearly 30% dying within a span of 3 months. In Africa, intracranial aneurysms pose a serious health challenge, where disparities in healthcare provision and limited resources act as a constraint to disease management. This also indicates the need for effective treatment alternatives and diagnostic techniques in healthcare facilities to successfully manage the condition. With the growing emphasis on improving healthcare infrastructure and rising preference for procedures with minimal postoperative risks, the Middle East and Africa intracranial aneurysm market demand is expected to witness a surge in the forecast period.

The market share is influenced by the rise in clinical data registries for post-marketing surveillance to evaluate the safety and efficacy of medical devices. For instance, INSPIRE-A is an international registry sponsored by Medtronic plc, engaged in the assessment of flow-diverter imaging results, boasting over 1,400 participants enrolled from more than 40 sites including South Africa, and the United Arab Emirates (UAE). This high-volume global study monitors and analyzes outcomes in intracranial aneurysm patients treated with Medtronic neurovascular medical devices such as Flex, Shield, and Vantage flow diverters. The findings from such registries are crucial to advancing endovascular aneurysm care in the region. Additionally, these studies have the potential to inform device development and stimulate innovation in product design, which is likely to elevate the market value.

Middle East and Africa Intracranial Aneurysm Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Market Breakup by Treatment Type

  • Endovascular Coiling
  • Surgical Clipping
  • Flow Diverters
  • Other Treatment Types

Market Breakup by End User

  • Hospitals
  • Clinics
  • Others

Market Breakup by Country

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Leading Players in the Middle East and Africa Intracranial Aneurysm Market

The key features of the market report include funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Stryker
  • B. Braun Melsungen AG
  • Medtronic
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Raumedic AG
  • Johnson & Johnson
  • Codman Neuro (Integra Lifesciences)
  • Microvention Inc.
  • Integra Lifesciences Corporation
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

FAQs

What is the Middle East and Africa intracranial aneurysm market forecast outlook for 2024-2032?
The Middle East and Africa intracranial aneurysm market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 8.8% during the forecast period of 2024-2032 and is likely to reach a market value of USD 2.6 billion by 2032.

What are the major factors aiding the Middle East and Africa intracranial aneurysm market demand?
The rising healthcare expenditures and advancements in minimally invasive treatments are fuelling the demand for the market.

What are the major Middle East and Africa intracranial aneurysm market trends?
One of the significant trends in the market is the rise in clinical data registries for post-marketing surveillance of medical devices. For instance, Medtronic sponsored INSPIRE-A (an international registry) which monitors and analyzes outcomes in intracranial aneurysm patients treated with Medtronic neurovascular medical devices.

What is the market segmentation based on the type?
Based on the type, the market is segmented into endovascular coiling, surgical clipping, and flow diverters, among others.

What is the major end use of the intracranial aneurysm?
The major end use includes hospitals and clinics, among others.

What is the market segmentation by countries?
The market segmentation by countries includes Saudi Arabia, the United Arab Emirates, Nigeria, and South Africa, among others.

Who are the key players involved in the Middle East and Africa intracranial aneurysm market?
The key players in the market are Stryker, B. Braun Melsungen AG, Medtronic, Terumo Corporation, MicroPort Scientific Corporation, Raumedic AG, Johnson & Johnson, Codman Neuro (Integra Lifesciences), MicroVention Inc., and Integra Lifesciences Corporation.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Middle East and Africa Intracranial Aneurysm Market Overview
3.1 Middle East and Africa Intracranial Aneurysm Market Historical Value (2017-2023)
3.2 Middle East and Africa Intracranial Aneurysm Market Forecast Value (2024-2032)
4 Middle East and Africa Intracranial Aneurysm Market Landscape*
4.1 Middle East and Africa Intracranial Aneurysm: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Middle East and Africa Intracranial Aneurysm: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 Middle East and Africa Intracranial Aneurysm Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Middle East and Africa Intracranial Aneurysm Market Segmentation (2017-2032)
6.1 Middle East and Africa Intracranial Aneurysm Market (2017-2032) by Type
6.1.1 Market Overview
6.1.2 Surgical Clipping
6.1.3 Endovascular Coiling
6.1.4 Flow Diverters
6.1.5 Others
6.2 Middle East and Africa Intracranial Aneurysm Market (2017-2032) by End-Use
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Clinics
6.2.4 Others
6.3 Middle East and Africa Intracranial Aneurysm Market (2017-2032) by Countries
6.3.1 Market Overview
6.3.2 Saudi Arabia
6.3.3 United Arab Emirates
6.3.4 Nigeria
6.3.5 South Africa
6.3.6 Others
7 Saudi Arabia Intracranial Aneurysm Market (2017-2032)
7.1 Saudi Arabia Intracranial Aneurysm Market (2017-2032) by Type
7.1.1 Market Overview
7.1.2 Surgical Clipping
7.1.3 Endovascular Coiling
7.1.4 Flow Diverters
7.1.5 Others
7.2 Saudi Arabia Intracranial Aneurysm Market (2017-2032) by End-Use
7.2.1 Market Overview
7.2.2 Hospitals
7.2.3 Clinics
7.2.4 Others
8 United Arab Emirates Intracranial Aneurysm Market (2017-2032)
8.1 United Arab Emirates Intracranial Aneurysm Market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Surgical Clipping
8.1.3 Endovascular Coiling
8.1.4 Flow Diverters
8.1.5 Others
8.2 United Arab Emirates Intracranial Aneurysm Market (2017-2032) by End-Use
8.2.1 Market Overview
8.2.2 Hospitals
8.2.3 Clinics
8.2.4 Others
9 Nigeria Intracranial Aneurysm Market (2017-2032)
9.1 Nigeria Intracranial Aneurysm Market (2017-2032) by Type
9.1.1 Market Overview
9.1.2 Surgical Clipping
9.1.3 Endovascular Coiling
9.1.4 Flow Diverters
9.1.5 Others
9.2 Nigeria Intracranial Aneurysm Market (2017-2032) by End-Use
9.2.1 Market Overview
9.2.2 Hospitals
9.2.3 Clinics
9.2.4 Others
10 South Africa Intracranial Aneurysm Market (2017-2032)
10.1 South Africa Intracranial Aneurysm Market (2017-2032) by Type
10.1.1 Market Overview
10.1.2 Surgical Clipping
10.1.3 Endovascular Coiling
10.1.4 Flow Diverters
10.1.5 Others
10.2 South Africa Intracranial Aneurysm Market (2017-2032) by End-Use
10.2.1 Market Overview
10.2.2 Hospitals
10.2.3 Clinics
10.2.4 Others
11 Regulatory Framework
12 Funding and Investment Analysis
12.1 Analysis by Funding Instances
12.2 Analysis by Type of Funding
12.3 Analysis by Funding Amount
12.4 Analysis by Leading Players
12.5 Analysis by Leading Investors
12.6 Analysis by Geography
13 Partnership and Collaborations Analysis
13.1 Analysis by Partnership Instances
13.2 Analysis by Type of Partnership
13.3 Analysis by Leading Players
13.4 Analysis by Geography
14 Supplier Landscape
14.1 Market Share by Top 5 Companies
14.2 Stryker
14.2.1 Financial Analysis
14.2.2 Product Portfolio
14.2.3 Demographic Reach and Achievements
14.2.4 Mergers and Acquisitions
14.2.5 Certifications
14.3 B. Braun Melsungen AG
14.3.1 Financial Analysis
14.3.2 Product Portfolio
14.3.3 Demographic Reach and Achievements
14.3.4 Mergers and Acquisitions
14.3.5 Certifications
14.4 Medtronic
14.4.1 Financial Analysis
14.4.2 Product Portfolio
14.4.3 Demographic Reach and Achievements
14.4.4 Mergers and Acquisitions
14.4.5 Certifications
14.5 Terumo Corporation
14.5.1 Financial Analysis
14.5.2 Product Portfolio
14.5.3 Demographic Reach and Achievements
14.5.4 Mergers and Acquisitions
14.5.5 Certifications
14.6 MicroPort Scientific Corporation
14.6.1 Financial Analysis
14.6.2 Product Portfolio
14.6.3 Demographic Reach and Achievements
14.6.4 Mergers and Acquisitions
14.6.5 Certifications
14.7 Raumedic AG
14.7.1 Financial Analysis
14.7.2 Product Portfolio
14.7.3 Demographic Reach and Achievements
14.7.4 Mergers and Acquisitions
14.7.5 Certifications
14.8 Johnson & Johnson
14.8.1 Financial Analysis
14.8.2 Product Portfolio
14.8.3 Demographic Reach and Achievements
14.8.4 Mergers and Acquisitions
14.8.5 Certification
14.9 Codman Neuro (Integra Lifesciences)
14.9.1 Financial Analysis
14.9.2 Product Portfolio
14.9.3 Demographic Reach and Achievements
14.9.4 Mergers and Acquisitions
14.9.5 Certifications
14.10 Microvention Inc.
14.10.1 Financial Analysis
14.10.2 Product Portfolio
14.10.3 Demographic Reach and Achievements
14.10.4 Mergers and Acquisitions
14.10.5 Certifications
14.11 Integra Lifesciences Corporation
14.11.1 Financial Analysis
14.11.2 Product Portfolio
14.11.3 Demographic Reach and Achievements
14.11.4 Mergers and Acquisitions
14.11.5 Certifications
15 Middle East and Africa Intracranial Aneurysm Market - Distribution Model (Additional Insight)
15.1 Overview
15.2 Potential Distributors
15.3 Key Parameters for Distribution Partner Assessment
16 Key Opinion Leaders (KOL) Insights (Additional Insight)
17 Company Competitiveness Analysis (Additional Insight)
17.1 Very Small Companies
17.2 Small Companies
17.3 Mid-Sized Companies
17.4 Large Companies
17.5 Very Large Companies
18 Payment Methods (Additional Insight)
18.1 Government Funded
18.2 Private Insurance
18.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The team strives to make this section as comprehensive as possible.

Companies Mentioned

  • Stryker
  • B. Braun Melsungen AG
  • Medtronic
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Raumedic AG
  • Johnson & Johnson
  • Codman Neuro (Integra Lifesciences)
  • Microvention Inc.
  • Integra Lifesciences Corporation

Methodology

Loading
LOADING...

Table Information